STEVE JUNES: Open Payments
NPI 1174125512 · HOMESTEAD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,393 in 40 payments from 13 companies in 2025. Trend: 2023 $838 · 2024 $1,185 · 2025 $1,393
Food & beverage: $1,393
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 3 | $254 |
| Madrigal Pharmaceuticals | 7 | $253 |
| PFIZER INC. | 6 | $229 |
| Ardelyx, Inc. | 8 | $200 |
| ABBVIE INC. | 3 | $154 |
| Braintree Laboratories, Inc. | 3 | $63 |
| Gilead Sciences, Inc. | 2 | $52 |
| Aimmune Therapeutics, Inc. | 2 | $48 |
| Intercept Pharmaceuticals, Inc. | 2 | $46 |
| Janssen Biotech, Inc. | 1 | $28 |
Products named: VOQUEZNA, REZDIFFRA, VELSIPITY, IBSRELA, SKYRIZI, ZENPEP, OCALIVA, SUFLAVE.
Industry payments across FL — which companies pay providers there.
